Healthcare Transformation

Changi General Hospital’s CEO discusses SMART hospitals and healthcare systems at RED 2024

Changi General Hospital (CGH) through the Office of Innovation, Centre for Healthcare & Assistive Robotic Technology and AI & Data Office has embarked on a generative AI journey using real-time big data, analytics, predictive algorithms and automation, melding man with technology to improve healthcare delivery and to future-proof an ageing workforce. CGH’s CEO, Clinical Professor

Changi General Hospital’s CEO discusses SMART hospitals and healthcare systems at RED 2024 Read More »

Building bridges: connecting with customers in the new era of laboratory diagnostics

The global landscape of laboratory diagnostics is undergoing a rapid transformation, driven by the emergence of new devices, business models, and a growing focus on patient-centricity. This presentation by Ms Daria Goryakina, Co-Founder & Managing Partner of HELIX Group, explores the evolving landscape of laboratory diagnostics and its business models, highlighting key trends and innovations.

Building bridges: connecting with customers in the new era of laboratory diagnostics Read More »

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem

In early 2023, The Mayo Clinic restructured its laboratory operations to enable the vision of a connected, interoperable, global diagnostics ecosystem. Dr William Morice II, CEO of Mayo Collaboratives Services, will share why this ecosystem is critical for patients and how the team is overcoming barriers.

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem Read More »

Partnering patients: strengthening the patient voice within health systems in Asia Pacific

Partnering Patients Strengthening the Patient Voice within Health Systems in Asia Pacific _thumbnail

Today, patient experience (based on experience at a single point of interaction) is built into qualitative feedback assessments at many health institutions, but patient engagement (based on consistent and proactive touchpoints in a person’s health journey) are frequently overlooked. In this panel, speakers will discuss how health systems in APAC can adopt an effective patient

Partnering patients: strengthening the patient voice within health systems in Asia Pacific Read More »

‘Real world evidence’ and clinical labs: a brief introduction

‘Real world evidence’ and clinical labs: a brief introduction

As public and private healthcare organisations around the world become increasingly aware of the power of ‘real world evidence’ (RWE) in developing and evaluating medical products, many are launching pilots and seeking policy guidance to explore the opportunity. While biopharma companies have been active in RWE for years, however, in vitro diagnostics manufacturers and clinical

‘Real world evidence’ and clinical labs: a brief introduction Read More »

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

Advancing Women’s Health: Project Teal drives cervical cancer screening in Hong Kong

  To find out more about the Karen Leung Foundation and the work they do, please click here. In Hong Kong, cervical cancer ranked as the 8th most common cancer and cause of mortality amongst women in 2019 [1]. Despite a national screening programme implemented in 2004, studies show that close to 40% of women

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong Read More »

What is Precision Public Health and why does it matter to clinical labs?

What is ‘Precision Public Health’ and why does it matter to clinical labs?

To effectively manage healthcare systems, public health practitioners have to constantly weigh trade-offs between the needs of society at large and those of specific sub-populations. In the absence of detailed population health data and tools for public health management, these trade-offs can raise difficult operational and ethical questions. The COVID-19 pandemic showed how challenging these

What is Precision Public Health and why does it matter to clinical labs? Read More »

IVD New Technology Summit showcases push toward payment reform in China

IVD New Technology Summit showcases push toward payment reform in China

This article was written by Chris L. Hardesty, an independent expert on global health-related policy matters, particularly pertaining to economically-viable innovation access programmes. Like many countries in the Asia-Pacific region and beyond, pricing of medical equipment, including in vitro diagnostic (IVD) technologies, remains a hot-button item in China. While many stakeholders recognise the value of

IVD New Technology Summit showcases push toward payment reform in China Read More »

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)

In 2019, Dr Thomas Grogan published Chasing the Invisible, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis. In the third instalment of this three-part series on Dr Grogan’s life and career, we explore some of the key lessons from

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3) Read More »

Scroll to Top